1. Academic Validation
  2. Development and validation of a UHPLC-qTOF-MS method for quantification of fuziline in rat plasma and its application in a pharmacokinetic study

Development and validation of a UHPLC-qTOF-MS method for quantification of fuziline in rat plasma and its application in a pharmacokinetic study

  • Biomed Chromatogr. 2014 Dec;28(12):1707-13. doi: 10.1002/bmc.3210.
Yun-xia Li 1 Xiao-hong Gong Yan Li Ruo-qi Zhang Liang Xiong Xiao-fang Xie Cheng Peng
Affiliations

Affiliation

  • 1 Pharmacy College, Chengdu University of Traditional Chinese Medicine, 1166 Liutai Road, Chengdu, 611137, China; The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine, 1166 Liutai Road, Chengdu, 611137, China; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, 1166 Liutai Road, Chengdu, 611137, China.
Abstract

A specific and sensitive UHPLC-qTOF-MS method was developed and validated for quantification of fuziline in rat plasma after oral administration of three dosages. The analyte was separated on an Acquity UPLC BEH C18 column with a total running time of 3 min using a mobile phase of 0.1% formic acid aqueous solution and methanol (80:20, v/v) at a flow-rate of 0.25 mL/min. The calibration curves for fuziline showed good linearity in the concentrations ranging from 1 to 200 ng/mL with correlation coefficients >0.997. The precision, accuracy, recovery and stability were deemed acceptable. The method was applied to a pharmacokinetics study of fuziline in rats. The mean half-life was 5.93, 6.13 and 5.12 h for 1, 2 and 4 mg/kg oral administration of fuziline, respectively. The peak concentration and area under the concentration-time curve increased linearly with the doses. The sum of these results indicated that, in the range of the doses examined, the pharmacokinetics of fuziline in rat was based on first-order kinetics.

Keywords

UHPLC-qTOF-MS; fuziline; pharmacokinetics.

Figures
Products